How to use this book. List of abbreviations. Acoustic neuroma. Alzheimer's disease. Arnold-Chiari malformations. Ataxia telangiectasia. Bell's palsy. Broca's aphasia. Brown-Sequard syndrome. Cavernous Sinus syndrome. Central pontine myelinolysis. Charcot-Marie-Tooth disease. Creutzfeldt-Jacon disease. Encephalitis. Epilepsy. Extradural haematoma. Friedreich's ataxia. Guillain-Barre Syndrome. Horner's syndrome. Huntingdon's disease. Hydrocephalus. Internuclear ophthalmoplegia. Intracrancial venous thrombosis. Lambert-Eaton myasthenic syndrome. Lateral medullary syndrome. Lewy body dementia. Meningitis. Migraine. Motor neurone disease. Multiple sclerosis. Myasthenia gravis. Myotonic dystrophy. Neurofibromatosis. Normal pressure hydrocephalus. Parkinson's disease. Frontotemporal dementia. Idiopathic intracranial hypertension. Spina bifida. Stroke. Sturge-Weber syndrome. Subacute combined degeneration. Subarachnoid haemorrhage. Subdural haematoma. Syringomyelia. Trigeminal neuralgia. Tuberous sclerosis. Von Hippel-Lindau syndrome. Wernicke-Korsakoff syndrome. Wernicke's aphasia. Appendix I. Appendix II. Glossary.
Sunjay Parmar is a Core Medical Doctor based at Nottingham University Hospitals NHS Trust, UK. He is a Fellow of the Higher Education Academy and is internationally recognised for his work on learning strategies in medicine built on his background in competing in memory tournaments. Having completed Postgraduate qualifications in Medical Education, he has extensive experience teaching medical students and doctors, as well as writing MRCP questions for online question banks. Professor Dame Pam Shaw is Professor of Neurology at the University of Sheffield and Director of the Sheffield Institute for Translational Neuroscience (SITraN), one of the world's leading centres for ALS/MND research. She is a Clinician Scientist in Neurology and formerly a Wellcome Trust Senior Fellow in Clinical Science. For the last 8 years she has led the Clinical Studies Group for ALS/MND within the NIHR Dementia and Neurodegenerative Diseases (DeNDRoN) clinical research network which links 19 ALS/MND Care and Research Centres and has developed a network of 10 UK centres experienced in ALS clinical trials. Prof. Shaw has taken part in more than 15 ALS clinical trials, including roles as UK Chief Investigator and Steering Committee member and also including several academic led studies. She is an active member of the European Network for the Cure of ALS (ENCALS). She has been the recipient of the following awards: American Academy of Neurology Sheila Essey Award for outstanding research contribution into amyotrophic lateral sclerosis/ motor neuron disease (2001); UK Royal College of Physicians Jean Hunter Prize for research into nervous disorders (2006); the International ALS/MND Forbes Norris Award for excellence in research and compassion in clinical care (2007); UK NIHR Senior Investigator Award (2013); Dame Commander of the Order of the British Empire DBE for services to Neuroscience (2014); UK ACCEA Platinum Clinical Excellence Award (2014).